The Effect of Heart Sound and White Noise on Pain and Physiological Parameters During Hepatitis B Vaccine Injection
1 other identifier
interventional
99
1 country
1
Brief Summary
It can cause physiological and behavioral changes in infants such as pain, tachycardia, hypoxemia, increased blood pressure, grimacing, prolonged crying, and irritability. Vaccination is an important part of neonatal nursing care. Newborns express their pain nonverbally and behaviorally. Therefore, any pain assessment is based on the ability of others to recognize pain symptoms. This randomized controlled trial was planned to evaluate the effect of heart sound and white noise on pain and physiological parameters during intramuscular injection of hepatitis B vaccine in newborns. This randomized controlled study used parallel trial design.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 17, 2024
CompletedFirst Posted
Study publicly available on registry
February 26, 2024
CompletedStudy Start
First participant enrolled
April 24, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 29, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 29, 2025
CompletedApril 26, 2024
April 1, 2024
1.3 years
February 17, 2024
April 24, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The Newborn Infant Pain Scale (NIPS)
Used to assess behavioral and physiological pain responses of preterm and term infants. The Neonatal Infant Pain Scale is a Likert-type scale consisting of 6 parameters including facial movements (0; relaxed, 1; restless), crying (0; no crying, 1; moaning, 2; loud crying), breathing (0; relaxed, 1; variable-irregular), arm (0; relaxed-free, 1; flexion-extension), leg (0; relaxed-free, 1; flexion-extension) and sleep-wakefulness (0; sleep-wakefulness peaceful, 1; restless). According to the scale, 7 is interpreted as the highest level of pain and 0 as the lowest level of pain. A high score indicates greater severity of pain.
15 minutes
Secondary Outcomes (3)
oxygen saturation
15 minutes
heart rate
15 minutes
Crying Time
15 minutes
Study Arms (3)
Heart sound group
EXPERIMENTALIn the heart sound group, the heart sound with an average heart rate of 70 beats is transmitted to the loudspeaker via an Mp3 player. Two small 200 W loudspeakers (SONY®)/"JBL" brand loudspeakers are used, placed on either side of the newborn's head, 30 cm from the newborn's ears.
White noise group
EXPERIMENTALIn the white noise group, the mother of the baby is told that the white noise to be used in the study will be used for pain relief. For the white noise, the musician Osman Orhan's colic album, which was released by the production and often used in the literature. The song "Bebeğiniz Ağlamasın Pt-3" from the album "Kolik" will be used (permission to use it in this work has been granted by ON Music Production). The volume is set to 45 db. The "JBL" loudspeaker is placed on the newborn's toe 5 minutes before the procedure, about 30 cm from the newborn's ear, and white noise is played 5 minutes before, during (at the 1st minute) and 5 minutes after the administration of the Hep B vaccine.
Control
NO INTERVENTIONNewborns in the control group will not receive any intervention other than Hepatitis B vaccination.
Interventions
In the Heart sound group, this sound will be played to the newborn 5 minutes before Hep B vaccine administration, during the procedure (at 1 minute) and 5 minutes after Hep B vaccine administration
Musician Osman Orhan's song "Bebeğiniz Ağlamasın" from his album Kolik will be used for white noise. The volume will be set to 45 db.
Eligibility Criteria
You may qualify if:
- Gestational age of 38-41 weeks,
- Newborn birth weight \>2500 g
- Stable vital signs before the procedure,
- Postanatal age between 2-28 days,
- No contraindications to the administration of hepatitis B vaccine
- Delivery of the newborn to the mother after birth
- Consent of the parents of the newborn to participate in the study
- Fasting less than 3 hours/30 minutes before feeding
- A valid score on the newborn hearing screening test
- Newborn not crying before vaccination
You may not qualify if:
- Newborn babies requiring respiratory support,
- Newborns with any neurological disorder (seizures)
- Newborns taking opiates or born to mothers taking opiates
- Newborns receiving muscle relaxants, sedatives, analgesics
- Babies with major congenital anomalies
- Neonates with an APGAR score of less than 7 at 5 minutes
- Neonates who have undergone surgery
- Newborns with birth trauma (especially rapid delivery)
- Conditions that may prevent communication with parents (e.g. speech problem)
- Hearing impairment
- Newborns who will be transferred to another hospital
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bartın University
Bartın, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 17, 2024
First Posted
February 26, 2024
Study Start
April 24, 2024
Primary Completion
August 29, 2025
Study Completion
August 29, 2025
Last Updated
April 26, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share